Description: Medical device design, development and manufacturing with BioMg® magnesium alloy technology
Chronic Kidney Disease is a significant and costly health care challenge. More than 2 million people worldwide are receiving treatment with dialysis or kidney transplants, yet this may only represent 10 percent of those people needing treatment.
Most patients are treated with hemodialysis which requires vascular access. The preferred method of vascular access is the AV Fistula, but it has a failure rate of approximately 50 percent. There is an unmet clinical need for vascular access to treat kidney disease.
people in the U.S. are afflicted with chronic kidney disease